Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bleomycin combined therapy versus intralesional bleomycin for plantar warts
2014-003339-21Phase 3Active
- Sponsor
- Institut d'Investigació Sanitària Pere Virgili
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of bleomycin in plantar wart (2 arms), sponsored by Institut d'Investigació Sanitària Pere Virgili. Primary endpoint: Primary therapeutic improvement in treatment group. Started Mar 2015; status: active.
02
Drugs
bleomycin
03
Conditions
plantar wart
Beyond the preview
Go deeper on 2014-003339-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003339-21.